Age at diagnosis and multiple primary cancers of the breast and ovary

Breast Cancer Research and Treatment

Volumn 41, Issue 1, 1996, Pages 21-29

  Suris Swartz, Phyllis J ^a   Schildkraut, Joellen M ^b   Vine, Marilyn F ^a   Hertz Picciotto, Irva ^a  

^a IL   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Age factors; Breast neoplasms; Nested case cohort studies; Ovarian neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; RISK;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 0029845457     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01807033     Document Type: Article

References (31)

1. Storm HH, Lynge E, Osterlind A, Jensen DM: Multiple primary cancer in Denmark 1943-80: Influence of possible underreporting and suggested risk factors. Yale J Biol and Med 59: 547-559, 1986
2. Lingeman CH: Environmental factors on the etiology of carcinoma of the human ovary: A review. Am J Industr Med 4: 365-379, 1983
3. Whittemore AS: Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in the United States. Cancer Supplement 71(2): 558-565, 1993
4. Merino MJ, Jaffe G: Age contrast in ovarian pathology. Cancer Supplement 71(2): 537-544, 1992
5. Colditz GA: Epidemiology of breast cancer. Findings from the nurse's health study. Cancer 71(4 Suppl): 1480-1489, 1993
6. Adami HO, Bergkvist L, Krusemo U, Persson I: Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort study. JNCI 73: 1049-1055, 1984
7. Lynch HT, Krush AJ: Carcinoma of the breast and ovary in three families. Surg Gynec Obstet 133: 644-648, 1971
8. Lynch HT, Albano WA, Lynch JF, Lynch PA, Campbell A: Surveillance and management of patients of high risk of ovarian carcinoma. Obstet Gynecol 59: 589-596, 1982
9. Thompson WD: Methodologic perspectives on the study of multiple primary cancers. Yale J Biol Med 59: 505-516, 1986
10. Shah S, Evans DGR, Blair V, Burnell LD, Birch JM: Assessment of relative risk of second primary tumors after ovarian cancer and the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer 72: 819-827, 1993
11. Amos CI, Struewing JP: Genetic epidemiology of epithelial ovarian cancer. Cancer 71: 566-572, 1993
12. King M-C, Rowell S, Love SM: Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA 269: 1975-1980, 1993
13. Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, Lynch JF, Ponder BAJ: Hereditary ovarian cancer heterogeneity in age at diagnosis. Cancer 67: 1460-1466, 1991
14. Schildkraut JM, Risch N, Thompson WD: Evaluating the genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 45: 521-529, 1989
15. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu O. Cochran C, Bennett LM, Ding W, Bell W, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Morris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Glodgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994
16. Bowcock AM: Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer. Breast Cancer Research and Treatment 28: 121-135, 1993
17. Claus EB, Risch NJ, Thompson WD: Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131: 961-972, 1990
18. Claus EB, Risch N, Thompson WD: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Research and Treatment 28: 115-120, 1993
19. Schottenfield D, Berg J: Incidence of multiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst 46: 161-170, 1970
20. Ewertz M, Mouridsen HT: Second cancer following cancer of the female breast in Denmark, 1943-80. NCI Monograph # 68: 325-329, 1985
21. Storm HH, Ewertz M: Second cancer following cancer of the female genital system in Denmark, 1943-80. NCI Monograph # 68: 331-340, 1985
22. Boice JD, Curtis RE, Kleinerman RA, Flannery JT, Fraumeni JF Jr: Multiple primary cancer in Connecticut, 1935-82. Yale J Biol Med 59: 533-545, 1986
23. Curtis RE, Hoover RN, Kleinerman RA, Harvey EB: Second cancer following cancer of the female genital system in Connecticut, 1935-82. NCI Monograph # 68: 113-137, 1985
24. Harvey ER, Brinton LA: Second cancer following cancer of the breast in Connecticut. NCI Monograph #68: 99-112, 1985
25. Prior P, Waterhouse JA: Multiple primary cancers of the breast and ovary. Br J Cancer 44: 628-636, 1981
26. Breslow NE: Analysis of survival data under the proportional hazards model. Int Stat Rev 43: 45-58, 1975
27. Lynch HT, Watson P, Lynch JF, Conway TA, Fili M: Hereditary ovarian cancer: heterogeneity in age at onset. Cancer 71: 589-593, 1993
28. Kramer BS, Gohagen J, Prorok PC, Smart C: A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 71: 589-593, 1993
29. Feuer EJ, Wun LM: How much of the recent rise in breast cancer incidence can be explained by mammography utilization? A dynamic population model approach. Am J Epidemiol 136: 1423-1436, 1992
30. Ries LA: Ovarian cancer: Survival and treatment differences by age. Cancer 71: 517-523, 1993
31. Schildkraut JM, Collins K, Dent GA, Tucker JA, Barrett JC, Berchuck A, Body J: Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer. Am J Obstet Gynecol 172: 908-913, 1995